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Abstract
Cationic liposomes complexed with DNA have been used extensively as non-viral vectors for the intracellular delivery of
reporter or therapeutic genes in culture and in vivo. We examined the relationship between the characteristics of the
lipoplexes, their mode of interaction with monocytic THP-1 cells and their ability to transfect these cells. We determined the
size and j potential of cationic liposomes (composed of 1,2-dioleoyl-3-(trimethylammonium) propane (DOTAP) and its
mixtures with neutral lipids), and lipoplexes at different (+/3) charge ratios. As the (+/3) charge ratio of the lipoplexes
decreased to (1/1), a significant reduction in j potential and an increase in size was observed. The increase in size resulted
from fusion between liposomes promoted by DNA, as demonstrated by a lipid mixing assay, and from aggregation of the
complexes. Interaction of liposomes and lipoplexes with THP-1 cells was assessed by monitoring lipid mixing (‘fusion’) as
well as binding and cell association. While no lipid mixing was observed with the 1/2 (+/3) lipid/DNA complexes, lipoplexes
with higher (+/3) charge ratios underwent significant fusion in conjunction with extensive cell binding. Liposome binding to
cells was dependent on the positive charge of the liposomes, and their fusion could be modulated by the co-lipid. DOTAP/
phosphatidylethanolamine (1:1) liposomes fused with THP-1 cells, unlike DOTAP/phosphatidylcholine (1:1) liposomes,
although both liposome types bound to the cells to a similar extent. The use of inhibitors of endocytosis indicated that fusion
of the cationic liposomes with cells occurred mainly at the plasma membrane level. The presence of serum increased the size
of the cationic liposomes, but not that of the lipoplexes. Low concentrations of serum (3%) completely inhibited the fusion of
cationic liposomes with cells, while inhibiting binding by only 20%. Our results suggest that binding of cationic liposomes and
lipoplexes to cells is governed primarily by electrostatic interactions, whereas their fusion is regulated by the lipid
composition and sterically favorable interactions with cell surface molecules. In addition our results indicate no correlation
between fusion of the lipoplexes with the plasma membrane and the levels of transfection. ß 1999 Elsevier Science B.V. All
rights reserved.
Keywords: Cationic liposome; Lipoplex; Membrane fusion; Transfection; THP-1 cell
1. Introduction
Recent studies have shown that gene therapy con-
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stitutes a promising strategy for the treatment of
cancer, infectious diseases and hereditary disorders
[1^4]. Delivery of therapeutic genes into cells with
high e⁄ciency, i.e. with high levels of gene expression
in a large percentage of treated cells, and in a stable
manner, is a crucial issue in gene therapy [5,6]. Cat-
ionic liposomes have proven to be useful tools for
delivery of genes and antisense oligonucleotides
into cells in culture and in vivo [7^13]. For example,
the delivery of the gene encoding the chloride trans-
porter into the lungs of transgenic mice lacking this
gene [14], and into cystic ¢brosis patients [15] via
cationic liposomes partially corrected this defect.
Cationic liposomes have several advantages as
gene transfer vectors over viruses. Unlike viral vec-
tors, cationic liposomes can be used to transfer DNA
of essentially unlimited size. Since plasmid-liposome
complexes (‘lipoplexes’ [16]) lack proteins, they are
not likely to evoke immunogenic or in£ammatory
responses. Moreover, they cannot replicate or recom-
bine to form an infectious agent and have low inte-
gration frequency [5,17]. Nevertheless, lipoplexes also
present several de¢ciencies, such as the low e⁄ciency
of transfection and extensive interaction with nega-
tively charged macromolecules in plasma and cell
surfaces, which may be detrimental.
Despite the extensive use of cationic liposomes for
gene delivery in vitro and in vivo [7,15,18^21] the
mechanisms by which they deliver DNA into cells
is not well understood. Initial studies suggested that
they fused with the plasma membrane and that the
fusion process mediated the entry of DNA into the
cytoplasm [7,8,18]. These interpretations were based
on the observation of di¡use £uorescence on the cell
surface following the interaction of liposomes con-
taining rhodamine-phosphatidylethanolamine (Rh-
PE) in their membrane, and the correlation of this
£uorescence with the ability of DOTMA/DOPE, but
not DOTMA/DOPC, liposomes to mediate transfec-
tion. Supporting evidence was provided by the ability
of cationic liposomes to fuse with erythrocyte mem-
branes [22,23]. Questions remain as to whether the
topology of the cationic liposome-DNA complexes
allows the entry of the DNA through a fusion event,
and whether this event takes place at the plasma
membrane or in endocytotic vesicles or endosomes.
Other studies have indicated that endocytosis of the
lipoplexes is another possible mechanism of intracel-
lular entry [24^26]. However, the problem of how the
lipoplex induces the disruption of the endosome in
order to gain access into the cytoplasm still needs to
be resolved. Furthermore, electron microscopic ob-
servations are likely to miss rapid fusion events that
take place at the plasma membrane, and to focus on
lipoplexes in endocytotic vesicles that are readily de-
tectable. Alternative methods, such as £uorescence
dequenching, need to be employed to ascertain the
rate and extent of fusion events at either the plasma
membrane or the endosomal membrane, or both.
Recently it has been proposed that the interaction
of cationic lipids with the endosome membrane in-
duces £ip-£op of negatively charged phosphatidylser-
ine molecules in the cytoplasmic lea£et to the lume-
nal lea£et, and that this lipid displaces the DNA
from its complex with the cationic lipid [27].
Although elegant and useful, this hypothesis does
not account for the nature of the initial intermem-
brane interaction that then leads to the transbilayer
movement of lipids. In addition to the above hypoth-
eses on the mechanism of DNA entry, van der
Woude et al. [28] have suggested the formation of
a pore in the plasma membrane, based on the hemo-
lytic activity of lipoplexes. In this case, whether the
DNA permeates through the pore or whether the
breakdown of the permeability barrier of the cell
membrane is only a by-product of the fusion reaction
must be resolved.
Similar to what has been described for divalent
cation-induced fusion of anionic liposomes [29], mul-
tivalent anions, oligonucleotides or DNA trigger the
fusion of cationic liposomes [23,30^32]. The presence
of nucleic acids leads to the formation of clusters
with surface charge and size that are di¡erent from
the original cationic liposome preparation, depend-
ing on the lipid/DNA (+/3) charge ratio.
To gain insights into the questions raised above,
we performed a systematic study of the interaction of
cationic liposomes and lipoplexes with monocytic
leukemia (THP-1) cells, in the presence or absence
of serum in the culture medium. We quantitated lipid
mixing between cationic liposomes induced by DNA
at the di¡erent charge ratios. We examined the proc-
ess of membrane lipid mixing between cationic lip-
osomes and the cells, by monitoring the dequenching
of a non-exchangeable £uorescent probe embedded
in the liposome membrane. We assessed the e¡ects
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of the lipid/DNA (+/3) charge ratio, endocytosis in-
hibitors, and serum on membrane lipid mixing. We
also established the levels of transfection under these
conditions. Some of our results have been presented
earlier in preliminary form [33,34].
2. Materials and methods
2.1. Materials
The cationic lipid 1,2-dioleoyl-3-(trimethylammo-
nium) propane (DOTAP), egg phosphatidylcholine
(PC), phosphatidylethanolamine (PE) produced by
transphosphatidylation of PC, poly(ethylene glycol)
(2000) distearoyl phosphatidylethanolamine) (PEG-
DSPE) and L-K-phosphatidylethanolamine-N-(liss-
amine rhodamine B sulfonyl) (Rh-PE) were pur-
chased from Avanti Polar Lipids (Alabaster, AL).
NaN3, NaF, antimycin A, ethidium bromide
(EtBr), DNA from calf thymus, and N-[2-hydroxy-
ethyl]piperazine-NP-[2-ethanesulfonic acid] (HEPES)
were obtained from Sigma (St. Louis, MO). All the
other chemicals and reagents used were of analytical
grade.
2.2. Preparation of cationic liposomes and their
complexes with DNA
Large unilamellar cationic liposomes (LUV) were
prepared by multiple extrusion of multilamellar lip-
osomes (MLV). Brie£y, lipids dissolved in CHCl3
were mixed at the desired molar ratio and dried in
a rotatory evaporator. The dried lipid ¢lms were hy-
drated in HEPES-bu¡ered saline (HBS; 150 mM
NaCl, 10 mM HEPES, pH 7.4) at a ¢nal lipid con-
centration of 5 mM. The resulting MLV were ex-
truded 5 times through two stacked polycarbonate
¢lters of 100 nm pore diameter using a Lipex Bio-
membranes (Vancouver, BC) high pressure extrusion
device. Phospholipid concentrations were determined
by an assay for phosphate [35]. Liposomes were la-
beled by incorporating Rh-PE at a self-quenching
concentration (5 mol% of total lipid). Liposome/
DNA complexes (lipoplexes) were prepared by mix-
ing appropriate amounts of DNA (also in HBS bu¡-
er) with the liposomes in order to obtain the desired
(+/3) charge ratio.
2.3. Cells
THP-1 cells, a human monocytic leukemia cell
line, were obtained from the UCSF Cell Culture Fa-
cility (San Francisco, CA) and maintained at 37‡C
under 5% CO2, in RPMI 1640 medium containing 25
mM HEPES bu¡er and 2% sodium bicarbonate, sup-
plemented with 10% heat-inactivated fetal bovine se-
rum (FBS) (Biochrom KG, Berlin) and antibiotics
(100 Wg/ml of streptomycin and 1 unit/ml of penicil-
lin). For fusion, binding and cell association studies,
the cells were harvested by centrifugation at 180Ug
for 7 min at room temperature, washed twice in phe-
nol red-free RPMI 1640 containing 25 mM HEPES
bu¡er (pH 7.4), resuspended in the latter medium at
a stock cell density of 20U106 cells/ml and kept on
ice in polypropylene centrifuge tubes until use on the
same day. Cell viability was determined by Trypan
blue exclusion and was routinely above 95%.
2.4. Physico-chemical characterization of liposomes
and their complexes with DNA (lipoplexes)
Liposomes and lipoplexes were characterized with
respect to their size and j potential using a Malvern
Autosizer II C (Malvern Instruments, UK) and a
Coulter DELSA 440 (Coulter Corporation, Miami,
FL), respectively. The DELSA 440 is a laser-based
multi-angle particle electrophoresis analyzer that
measures the electrophoretic mobility and j potential
distribution simultaneously with the hydrodynamic
size of particles in suspension. The j potential was
automatically calculated from the electrophoretic
mobility based on the Helmholtz-Smoluchowski for-
mula [36]. Although adsorption of cationic liposomes
onto the camera wall was noticeable, this appeared
not to interfere with the reproducibility of the meas-
urements.
Cationic liposomes and their complexes with DNA
were diluted 10 times with HBS before analysis at
25‡C. All the liposome/DNA complexes were pre-
pared immediately before analysis. Samples of the
prepared complexes were placed in the measuring
cell, whose position was adjusted to cover a previ-
ously determined stationary layer, and an electric
current of 3.0 mA was applied. Measurements were
recorded and the j potential was calculated for each
scattering angle (8.6‡, 17.1‡, 25.6‡ and 34.2‡). Data
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represent the mean þ standard deviation obtained for
the di¡erent angles of two measurements. All cati-
onic liposome/DNA complexes showed a unimodal
distribution for j potential, while in size measure-
ments a polymodal distribution was observed.
2.5. Ethidium bromide-DNA interaction
Plasmid DNA (0.138 mmol) was incubated with
0.2 mg/ml EtBr, in a ¢nal volume of 3 ml HBS.
Following 2 min incubation, di¡erent amounts of
the DOTAP liposome suspension were added in or-
der to obtain the desired (+/3) lipid/DNA charge
ratios. EtBr £uorescence was continuously monitored
at 610 nm in a Spex £uorometer (SPEX Industries,
Edison, NJ) (excitation wavelength: 500 nm; 1.0 mm
excitation and 2.0 mm emission slits).
2.6. Fusion (lipid mixing) assay
Fusion (lipid mixing) between THP-1 cells and
cationic liposomes was evaluated at 37‡C by contin-
uously monitoring the dequenching of Rh-PE incor-
porated in the liposome membrane at a self-
quenched concentration. Fusion experiments were
carried out using various concentrations of liposomes
and THP-1 cells. Results are presented for a lipid
concentration of 20 WM (liposomes) and 1U106
cells/ml (THP-1 cells), which were determined to be
the optimal concentrations in terms of £uorescence
increase (data not shown). The ¢nal incubation vol-
ume was 2 ml. The extent of fusion was measured
following a 30 min incubation of the cationic lipo-
somes and cells, and is given as a percentage of the
maximal £uorescence. The £uorescence scale was
calibrated, such that the initial £uorescence of the
Rh-PE-labeled liposomes and cell suspension was
set at 0% £uorescence. Maximal £uorescence
(100%) was obtained upon addition of Triton X-
100 at a ¢nal concentration of 0.5% (v/v). Fluores-
cence measurements were performed in the SPEX
£uorometer. The £uorescence was read at an excita-
tion wavelength of 568 nm and an emission wave-
length of 586 nm using 0.5 and 1 mm slits in the
excitation and emission channels, respectively. The
sample chamber was equipped with a magnetic stir-
ring device and the temperature was controlled with
a thermostated circulating water bath.
To inhibit endocytosis at 37‡C, THP-1 cells were
pre-treated with 1 Wg/ml of antimycin A, 10 mM
NaF, 0.1% (w/v) sodium azide for 30 min at 37‡C
as described before [37,38]. Fusion was measured in
the presence of these metabolic inhibitors. The e¡ect
of liposome composition on the extent of fusion was
investigated by preparing DOTAP liposomes con-
taining di¡erent amounts of PC, PE or PEG-
DSPE. To evaluate the e¡ect of DNA on fusion,
complexes of DOTAP or DOTAP/PE with DNA
were prepared at di¡erent (+/3) charge ratios, imme-
diately before use. The e¡ect of serum was studied
following its addition to the reaction medium at var-
ious concentrations before addition the cationic lip-
osomes to the cells.
2.7. Binding and cell association assays
The binding experiments were carried out at 4‡C,
while cell association studies were performed at
37‡C. In both cases, a mixture containing 1U106
cells/ml and 20 WM of £uorescently labeled cationic
liposomes (¢nal volume 2 ml) in polypropylene tubes
was continuously stirred using a magnetic stirrer on
ice or in a water bath, respectively. After various
incubation times, samples were centrifuged at
180Ug for 10 min at 4‡C. The supernatant and the
pellet were separated and kept at 4‡C until use. The
£uorescence of the supernatant and the pellet (resus-
pended in 2 ml of RPMI medium) was measured at
37‡C, following detergent lysis. The e¡ect of DNA
and serum was evaluated in the same way as de-
scribed above.
2.8. DNA-induced liposome-liposome fusion
DNA-induced fusion between cationic liposomes
was monitored by the dequenching of the £uorescent
probe Rh-PE incorporated into the membrane of one
population of liposomes at a self-quenching concen-
tration (5 mol%). Fusion was initiated by adding
di¡erent amounts of DNA into a cuvette containing
4 WM of labeled and 16 WM of unlabeled cationic
liposomes in 1.9 ml of HBS to obtain the desired
(+/3) charge ratio. Fusion was monitored for 3 min
at 37‡C. Parallel experiments were performed in the
presence of serum.
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2.9. Cell viability
Cell viability was measured following incubation
of cells with liposomes or liposome-DNA complexes
for di¡erent periods of time. Membrane integrity was
determined by lactate dehydrogenase (LDH) assay
[39] or by Trypan blue exclusion. The reduction ca-
pacity of mitochondrial dehydrogenases was deter-
mined by the 3-[4,5-dimethylthiazol-2-yl]-2,5-diphen-
yltetrazolium bromide (MTT) assay [40].
2.10. Transfection activity
The transfection activity of lipid/DNA complexes
was measured by luciferase expression from the plas-
mid pCMVluc (VR-1216 from Vical). THP-1 cells in
suspension were rinsed twice with serum-free me-
dium, resuspended in 0.3 ml of RPMI 1640 and
transferred to 48 well plates (at a cell density of
0.5U106 cells/well) before lipid/DNA complexes
were added. Lipid/DNA complexes were added gen-
tly to cells in a volume of 0.2 ml per well. After an
incubation for 4 h (in 5% CO2 at 37‡C) the medium
was replaced with RPMI 1640 containing 10% FBS,
and the cells were further incubated for 24 h. The
cells were then washed twice with phosphate-bu¡ered
saline (PBS) and 100 Wl of lysis bu¡er (Promega,
Madison, WI) were added to each well. The level
of gene expression in the lysates was evaluated by
measuring light production by luciferase using a scin-
Fig. 1. The e¡ect of DNA on the physico-chemical properties and on the fusion of DOTAP-containing liposomes. (A) DOTAP-con-
taining liposomes and their complexes with DNA were characterized with respect to j potential as described in Section 2. Liposomes
were prepared by extrusion of multilamellar vesicles in 10 mM HEPES, 150 mM NaCl, pH 7.4 as described in Section 2. Liposome-
DNA complexes were prepared at di¡erent lipid/DNA (+/3) charge ratios immediately before analysis. Total lipid concentration was
4.1 mM. (B) The mean particle size was measured 5 min after adding DNA to liposome suspensions (20 WM) by light scattering anal-
ysis. (C) Fusion was evaluated by measuring the extent of Rh-PE £uorescence dequenching, at 37‡C, upon addition of DNA to a mix-
ture of £uorescently labeled (4 WM) and unlabeled (16 WM) DOTAP liposomes (3 min incubation).
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tillation counter protocol (Promega). The protein
content of the lysates was measured by the Dc Pro-
tein Assay reagent (Bio-Rad, Hercules, CA) using
bovine serum albumin as the standard. The data
were expressed as ng of luciferase (based on a stand-
ard curve for luciferase activity), per mg of total cell
protein.
3. Results
3.1. Physico-chemical characterization of DOTAP-
containing liposomes and their complexes with
DNA
Signi¢cant changes occur in the physico-chemical
features of cationic liposomes upon their complex-
ation with negatively charged nucleic acids [31,41].
These changes are likely to alter the interaction of
cationic liposomes with cell membranes. The j po-
tential of the cationic liposomes and their complexes
with DNA provides a measure of their net charge,
while dynamic light scattering gives their mean par-
ticle size. Fig. 1 shows the values obtained for j
potential and mean particle size of liposome/DNA
complexes at di¡erent lipid/DNA (+/3) charge ra-
tios, as well as the extent of fusion between lipo-
somes. Complexation of DNA with DOTAP-con-
taining liposomes leads to a decrease in the values
of the j potential (Fig. 1A). The mean size of the
complexes was considerably larger than that of the
liposomes themselves, and varied from 260 nm for
the 6/1 complex to above 4500 nm for the 1/1 (+/3)
complex (Fig. 1B). The correlation between the ex-
tent of fusion between liposomes, measured as Rh-
PE £uorescence dequenching upon addition of DNA,
and the mean diameter of the resulting complexes are
also illustrated in Fig. 1B,C. Similar to the charge
ratio dependence of the mean diameter, the extent
of Rh-PE £uorescence dequenching was maximal at
the 1/1 lipid/DNA (+/3) charge ratio (Fig. 1C). It
appears that when the resulting complexes exhibit an
excess of positive or negative charge, electrostatic
repulsive forces prevent extensive aggregation and/
or fusion, thus leading to the formation of smaller
complexes. In contrast, extensive aggregation and
fusion are favored in the case of approximately neu-
tral complexes where repulsive forces are minimal.
3.2. Ethidium bromide intercalation
The intercalation of ethidium bromide in between
the base pairs of DNA results in a large enhancement
of £uorescence. The addition of cationic liposomes to
ethidium bromide-labeled DNA causes the conden-
sation of the DNA, extrusion of the ethidium bro-
mide, and a decrease in £uorescence [27,31]. Addi-
tion of DOTAP liposomes to DNA in HBS resulted
in a decrease of EtBr £uorescence up to the 1/1 (+/3)
charge ratio, as illustrated in Fig. 2. Subsequent ad-
dition of DOTAP liposomes up to a charge ratio of
2/1 (+/3) did not lead to any further decrease in the
£uorescence.
3.3. Fusion of DOTAP-containing liposomes with
THP-1 cells
The mode of interaction of lipoplexes with the
plasma membrane of the target cell and the intra-
cellular fate of the DNA component are not under-
stood well. Two of the hypotheses that describe the
mechanism of transfection mediated by cationic lip-
osomes are that: (i) fusion with the plasma mem-
brane results in cytoplasmic delivery of the genetic
material [7], and (ii) lipoplexes are internalized by
endocytosis [25,42]. These mechanisms are not mu-
tually exclusive, and may be active to a greater or
lesser extent in di¡erent cell types. We examined the
Fig. 2. E¡ect of addition of DOTAP-containing liposomes on
the interaction of ethidium bromide with DNA. Following ad-
dition of DNA (a) and incubation with ethidium bromide, dif-
ferent amounts of DOTAP liposomes were added in order to
obtain the desired (+/3) lipid/DNA charge ratios: 1/4 (b); 1/2
(c) ; 1/1 (d); 2/1 (e). The accessibility of EtBr to DNA was eval-
uated at 37‡C as described in detail in Section 2.
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fusion of DOTAP liposomes with THP-1 cells, and
the e¡ect on this process of zwitterionic lipids known
to have particular e¡ects on membrane fusion in
other experimental systems [29,43]. THP-1 cells
were chosen for these studies since they can be
used both in suspension and as adherent cells
[44,45] and because of our previous experience with
these cells in terms of liposome uptake and inhibition
of endocytosis [38].
Pure DOTAP liposomes fused extensively with
THP-1 cells, resulting in about 50% £uorescence de-
quenching within 30 min of addition of the liposomes
Fig. 3. (A) Fusion between liposomes and THP-1 cells. Fusion was monitored at 37‡C by the dequenching of Rh-PE incorporated
into the liposome membrane at 5 mol%. Liposomes were prepared as described in Section 2. The extent of fusion was measured after
30 min incubation of the liposomes with cells. Liposome concentration and cell density were 20 WM and 1U106 cells/ml, respectively.
The j potential values are indicated in the ¢gure for each liposome formulation. (B) E¡ect of inhibitors of endocytosis and of DNA
on the fusion of DOTAP-containing liposomes with THP-1 cells. THP-1 cells were pre-treated with inhibitors of endocytosis for 30
min at 37‡C and fusion was measured after 30 min incubation of the liposomes with treated or untreated (control) cells. Complexes
of DOTAP or DOTAP/PE with DNA were prepared at di¡erent (+/3) charge ratios and the extent of fusion was measured following
30 min incubation with cells.
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to the cells (Fig. 3A). When PE was included in the
membrane of DOTAP liposomes at 50 mole%, the
extent of fusion was not signi¢cantly a¡ected. In
contrast, the inclusion of 50 mole% PC completely
inhibited fusion, as expected from the fusion inhib-
itory e¡ect of PC in the divalent cation-induced fu-
sion of net anionic liposomes [46] or the fusion of
cationic liposomes with anionic liposomes [23]. In
mixed DOTAP/PE liposomes, as the mol fraction
of DOTAP was decreased at the expense of PE, the
extent of fusion with THP-1 cells was reduced.
Previous studies had indicated that the inclusion of
PEG-DSPE in phosphatidylserine-containing lipo-
somes inhibited calcium-induced fusion of the lipo-
somes [46,47]. When 5 mole% DSPE-PEG was in-
cluded in DOTAP liposomes, fusion of the
liposomes with THP-1 cells was also inhibited sub-
stantially (Fig. 3A).
3.4. E¡ect of inhibitors of endocytosis on liposome-
cell interactions
To evaluate the relative contribution of endocyto-
sis to the interaction of DOTAP-containing lipo-
somes with THP-1 cells, we measured the extent of
liposome-cell fusion in the presence of inhibitors of
endocytosis. The results in Fig. 3B show that inhib-
ition of endocytosis leads to only about 20% inhib-
ition of fusion, suggesting that fusion of the cationic
liposomes with THP-1 cells takes place primarily at
the plasma membrane. Independent experiments uti-
lizing £uorescence microscopy of THP-1 cells indi-
cated that endocytosis was indeed inhibited under
these conditions (unpublished data).
On the other hand, in order to exclude the possi-
bility that internalization and accumulation of some
cationic liposomes inside the endosomes could limit
the maximal extent of fusion (50%), we measured the
total cell association of DOTAP liposomes in the
presence or in the absence of inhibitors of endocyto-
sis. Experiments performed on total cell association,
which involves the combination of cell binding,
membrane fusion and endocytosis of the liposomes,
show that the percentage of liposomes that have as-
sociated with the cells is similar to that observed for
the extent of fusion (data not shown). Similar to
what was described in Fig. 3B, the presence of inhib-
itors of endocytosis did not signi¢cantly a¡ect the
extent of liposome-cell association up to 90 min of
incubation. This observation reinforces our previous
¢nding that fusion of cationic liposomes with THP-1
cells occurs mainly at the level of the plasma mem-
brane.
3.5. Binding studies
In order to obtain insights into the e¡ect of DNA
and liposome composition on the ability of cationic
liposomes to fuse with THP-1 cells, we also examined
the binding of the liposomes to the cells at 4‡C,
under which conditions no endocytosis is expected
to occur. As illustrated in Fig. 4, pure DOTAP lip-
osomes showed the greatest binding among the sev-
eral formulations examined. The increase in the per-
centage of PE in the liposome membrane resulted in
a decrease of liposome-cell binding, probably due to
a reduction in the electrostatic interactions between
positively charged liposomes and the negatively
charged cell surface. However, no signi¢cant e¡ect
on binding was observed upon addition of PC to
DOTAP liposomes in a (1/1) molar ratio. The di¡er-
ent behavior in terms of extent of cell binding be-
tween DOTAP/PE and DOTAP/PC liposomes may
be explained by the di¡erences in their net charge (as
illustrated by their j potential presented in Fig. 3A).
In contrast, inclusion of 5% of PEG-DSPE drasti-
cally reduced the binding capacity of the resulting
cationic liposomes. The binding of DOTAP or DO-
TAP/PE liposomes to THP-1 cells at 4‡C showed
saturation kinetics after a 90 min incubation, while
lipoplexes reached saturation after 15 min (data not
shown). Except for PC-containing liposomes a corre-
lation between liposome-cell binding and fusion abil-
ity could be established. The absence of any lipid
mixing between DOTAP/PC liposomes and the cell
membrane (Fig. 3A), despite extensive binding of the
liposomes to the cells, also supports our interpreta-
tion that the £uorescence dequenching is not due to
non-speci¢c probe transfer from bound liposomes to
the cell membrane.
3.6. E¡ect of DNA complexation on cationic
liposome-cell interactions
Complexation of DNA with DOTAP or DOTAP/
PE liposomes resulted in the inhibition of fusion.
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Fusion was completely abolished when the lipid/
DNA complexes exhibited a net negative charge
(Fig. 3B). Complexation of DNA with DOTAP lip-
osomes also led to a signi¢cant decrease in the bind-
ing of the resulting complexes to THP-1 cells, de-
pending on the (+/3) charge ratio (Fig. 4).
3.7. E¡ect of serum on fusion and binding between
DOTAP-containing liposomes and THP-1 cells
Transfection of certain cell types by some cationic
liposomal compositions is sensitive to the presence of
serum [7,48,49]. It is possible that negatively charged
macromolecules present in serum a¡ect the fusogenic
properties of cationic liposomes and thus their ability
to interact with cells. We therefore investigated the
e¡ect of serum on the physico-chemical properties of
the cationic liposomes and of their complexes with
DNA, as well as its e¡ect on liposome-cell interac-
tions.
When positively charged liposomes composed of
DOTAP or DOTAP/PE (1/1) were added to medium
containing 10% serum at 37‡C, a substantial aggre-
gation of the liposomes occurred as measured by
turbidity (data not shown). Incubation of DOTAP
liposomes with residual amounts of serum (1%) led
to the formation of aggregates (approx. 800 nm in
diameter) whose mean diameter further increased
when the serum concentration was raised up to 3%.
Further increase in serum concentration did not re-
sult in any signi¢cant change in the size of liposomes.
Under the same experimental conditions, completely
di¡erent results were observed when DOTAP lipo-
somes were complexed with DNA at a 4/1 lipid/
DNA (+/3) charge ratio, since serum had no e¡ect
on complex size (Fig. 5A).
The presence of serum drastically inhibited the fu-
sion of DOTAP or DOTAP/PE liposomes with cells,
even at very low concentrations, and fusion was
abolished in the presence of 3% serum (Fig. 5B).
To determine whether this inhibitory e¡ect was due
to inhibition of binding of liposomes to cells, we
evaluated the e¡ect of serum on binding (Fig. 5C).
Curiously, the presence of 3% serum caused only a
20% reduction in binding, although this concentra-
tion of serum was su⁄cient to completely inhibit
fusion. A strong inhibition of liposome-cell binding
was only observed when a relatively high concentra-
tion of serum was present in the medium (up to
20%). The e¡ect of increasing the percentage of se-
rum on the extent of lipoplex-cell binding was less
pronounced than its e¡ect on fusion.
3.8. Transfection activity
Transfection activity was a¡ected by the net
charge of the complexes. When lipoplexes presented
a net positive or neutral charge high levels of trans-
fection were observed. However, when they were net
negatively charged a reduction in the transfection
levels was observed (Fig. 6). A signi¢cant decrease
in the levels of luciferase gene expression was ob-
Fig. 4. Liposome-cell binding studies. The e¡ect of liposome composition and of addition of DNA to DOTAP liposomes. Liposomes
and their complexes with DNA were prepared as described in the legend to Fig. 1. Liposome-cell binding was measured after 15 min
incubation.
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served upon incubation of the complexes with the
cells in the presence of inhibitors of endocytosis,
demonstrating that endocytosis represents the major
route of intracellular gene delivery. This decrease
cannot be attributed to any toxic e¡ect of these com-
pounds on the cells as evaluated by the Alamar blue
assay (data not shown).
4. Discussion
The physico-chemical features of lipid-based gene
delivery systems play an important role in their in-
teraction with cellular membranes [50]. The mecha-
nisms by which cationic liposomes deliver DNA into
cells are not well understood, and are being investi-
gated. In early studies on gene or oligonucleotide
delivery via cationic liposomes, the proposed mecha-
nism was that following binding, the lipid-DNA or
lipid-oligonucleotide complexes fuse with the plasma
membrane of a target cell [7,51]. More recent studies
have shown that lipoplexes are ¢rst endocytosed and
then destabilize the endosomal membrane, thereby
micro-injecting the DNA into the cytoplasm [24^
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26,52]. The characteristics of the lipoplexes resulting
from the interaction of cationic lipids with DNA are
still largely unknown. The current study focused on
several types of interactions of lipoplexes with THP-1
suspension cells, namely cell binding and association,
fusion with the plasma and endosomal membranes,
and transfection. Our results emphasize the impor-
tance of the lipid-DNA electrostatic interactions in-
volved in the formation and properties of the result-
ing complexes. A signi¢cant decrease of the j
potential was observed when the lipid/DNA (+/3)
charge ratio decreased from 2/1 to 1/1. As more
DNA is complexed with cationic liposomes, the re-
pulsion between the liposomes is reduced. Further-
more, the multianionic DNA mediates the close ap-
proach of the liposomes, leading to aggregation and
fusion of the cationic liposomes. This results in an
enhancement of the sizes of the complexes. Upon
further addition of DNA, i.e. a decrease in the lip-
id/DNA (+/3) charge ratio, the complexes exhibit
much smaller sizes, as a result of the repulsion be-
tween the excess negative charges. DNA-induced fu-
sion between liposomes in complexes with lower or
higher (+/3) charge ratios than 1/1 is strongly inhib-
ited. Consequently, under these conditions the com-
plexes maintain their small sizes for long periods of
time. It is reasonable to assume that in addition to
partially neutralizing the positive charge of DOTAP,
DNA may form a bridge between the positively
charged polar headgroups of two apposing lipo-
somes. Dehydration of the membrane surface may
occur during the formation of the complexes due to
removal of bound water by DNA, as suggested by
Rupert et al. [30] and Du«zgu«nes et al. [23] for the
case of didodecylammonium bromide (DDAB)/dipi-
colinic acid complexes and polyanion-induced fusion
of dioleyloxypropyltrimethylammonium (DOTMA)
liposomes, respectively. The neutralization of the
positive charge results in a decrease of the e¡ective
size of the lipid polar headgroups, thus reducing the
ability of the lipids to form lipid bilayers, and in a
reduction in intervesicular electrostatic repulsion.
Fig. 5. The e¡ect of serum on the mean diameter of DOTAP liposomes and of their complexes with DNA (A), on liposome-cell fu-
sion (B) and on the extent of cell binding (C). Liposomes and liposome/DNA complexes were prepared as described in the legend to
Fig. 1 in the absence or presence of 3% serum. Liposome- or complex-cell binding and fusion were evaluated in the absence or pres-
ence of di¡erent amounts of serum, as described in detail in Section 2.
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This in turn would lead to more favorable conditions
for the induction of fusion, since aggregation would
be facilitated under these conditions [53].
Results obtained on the accessibility of EtBr to
DNA present in complexes with di¡erent lipid/
DNA (+/3) charge ratios show that, even in 1/1
complexes, DNA is completely condensed and cov-
ered by a lipid bilayer, and thus is most likely pro-
tected from nucleases. These observations, together
with the e¡ect of the addition of DNA on the j
potential of the complexes, indicate that all the cat-
ionic lipids interact electrostatically with nucleic
acids. This is only possible assuming that the ¢nal
structure of the liposomes in the complexes is not
spherical, but rather a planar lipid bilayer where
the positive charges of both lea£ets become available
to interact with DNA.
It should be noted that electrostatic interactions
between cationic liposomes or lipid-DNA complexes
with cells represent a key element in their interaction
with cells. Inclusion of PE in DOTAP-containing lip-
osomes (maintaining the total lipid concentration at
the expense of DOTAP) leads to a decrease in the
extent of liposome-cell fusion. Despite the fusogenic
properties of PE [25,45,46,54^57], the reduction of
the net positive charge of the liposomes due to the
presence of this lipid results in a lower extent of
binding and, consequently, of fusion. Neutral lipo-
somes composed of PC/PE (1/1), presenting a re-
duced binding ability, exhibit a very limited extent
of fusion with cells. Similar results were observed
upon inclusion of a low mole percentage of PEG-
DSPE in DOTAP liposomes. The masking e¡ect of
PEG on the charge of the liposomes, as illustrated by
the j potential measurements, drastically reduces
their binding and fusion capacity. Nevertheless, be-
sides the net charge of the liposomes, the nature of
the co-lipid used also plays an important role in lip-
osome-cell interactions. In fact, inclusion of PC in-
stead of PE in DOTAP-containing liposomes leads to
a decrease in the extent of liposome-cell fusion, this
being completely abolished at 1/1 (DOTAP/PC) mo-
lar ratio. Since binding ability was not a¡ected, we
can conclude that this inhibitory e¡ect was not due
to unfavorable electrostatic interactions, but rather
to a steric hindrance caused by the presence of the
large and highly hydrated polar headgroup of PC
[45,46].
Similar to the observations upon incorporation of
PE in DOTAP liposomes, association of nucleic
acids with DOTAP liposomes results in a signi¢cant
reduction in binding and fusion with the cells, both
being completely abolished when the complexes
present a net negative charge (1/2 charge ratio).
Fusion of the cationic liposomes with THP-1 cells
seems to occur mainly at the level of the cytoplasmic
membrane, since only 20% inhibition of fusion was
observed when cells were pre-incubated with inhibi-
tors of endocytosis. Similar results were obtained in
measurements of cell-associated liposomes at 37‡C,
where inhibitors of endocytosis decrease the cell as-
sociation by only about 10%, indicating that lipo-
somes are essentially associated with the plasma
membrane. Furthermore, the similarity between the
percentage of liposome-cell association and that of
the extent of fusion suggests that the great majority
of liposomes associated with the cells fuse with the
plasma membrane and that fusion with the endoso-
mal membrane, following endocytosis of the lipo-
somes, plays a minor role in the overall extent of
liposome fusion with cellular membranes at least
for this type of cells.
Incubation of cationic liposomes with serum leads
to an increase in their size, which is mainly due to
aggregation promoted by serum components. The
negatively charged serum proteins may form bridges
Fig. 6. Transfection of THP-1 cells in the presence or in the ab-
sence of endocytosis. Liposome/DNA complexes were prepared
as described in the legend to Fig. 1. Transfection activity was
measured by the expression of luciferase as described in Section
2.
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between cationic liposomes, as described for the ef-
fect of DNA. However, in contrast to what was ob-
served for DNA, the increase in size of the liposomes
is not due to fusion between them. It should be noted
that aggregation was not observed when complexes
prepared at high (+/3) charge ratios (4/1) were in-
cubated with serum. Apparently in this case the bind-
ing of serum proteins was not su⁄cient to overcome
the electrostatic repulsion between the complexes.
Fusion of cationic liposomes (DOTAP or DO-
TAP/PE) or of their DNA complexes with cells was
completely abolished in the presence of 3% serum.
This e¡ect cannot be attributed to the lack of bind-
ing, since even 20% serum was not su⁄cient to com-
pletely inhibit liposome-cell binding. At low percent-
ages of serum, its proteins may act as a physical
barrier, preventing fusion but not binding. More-
over, the large sizes of the liposomes observed under
these conditions may also limit their capacity to fuse
with cells. On the other hand, at higher serum con-
centrations, the presence of large amounts of nega-
tively charged proteins, besides constituting a phys-
ical barrier, also represents an electrostatic barrier
that prevents both fusion and binding.
Overall, our ¢ndings indicate that addition of nu-
cleic acids to cationic liposomes promotes a signi¢-
cant change in their physico-chemical properties as a
result of aggregation and fusion. Consequently, lip-
osome-cell interactions, particularly fusion, are dras-
tically a¡ected. Besides the unfavorable electrostatic
interactions, due to the presence of DNA or nega-
tively charged macromolecules present in serum, it
appears that the resulting size change of the com-
plexes also plays an important role in limiting lipid
mixing.
Taking into account our observations that fusion
of cationic liposomes with the plasma membrane is
strongly inhibited upon addition of DNA, it seems
that the only pathway of internalization of lipid-
DNA complexes in transfected cells is through endo-
cytosis. However, if fusion does not take place in the
presence of DNA it remains to be clari¢ed how
DNA is released from the endosomes into the cyto-
plasm. One possibility would be fusion/destabiliza-
tion between the liposomal and endosomal mem-
branes promoted by the high radius of curvature of
the latter membrane, as suggested by Xu and Szoka
[27].
Our studies with THP-1 cells have shown a signi¢-
cant level of complex fusion with the plasma mem-
brane and a low level of transfection. It should be
noted that the limited e⁄ciency of transfection can-
not be attributed to loss in cell viability, since no
toxic e¡ects were observed upon incubation of the
complexes with the cells. Inhibition of endocytosis
reduced signi¢cantly the extent of complex fusion,
the small level of fusion remaining being with the
plasma membrane, whereas transfection was almost
abolished. Hence, it appears that the main route of
transfection in this system relies on the endocytosis
of the complex.
This lack of correlation between fusion and trans-
fection, also previously observed by Stegmann and
Legendre [58] with adherent cells, may be partially
attributed to the heterogeneity of the complexes
formed upon addition of DNA to cationic liposomes.
The evaluation of the conditions leading to high lev-
els of transfection activity would be facilitated by the
development of methodologies for the preparation of
more homogeneous complexes. The fact that fusion
of the complexes with the plasma membrane does
not yield high levels of transfection, should not
lead prematurely to discard this route. First, other
cell types should be investigated, focusing on cells
with low rates of endocytosis. Second, this system
may be supplemented by means to direct the DNA
to the nucleus following the fusion of the complex
with the plasma membrane.
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